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Abstract
Background: Colorectal cancer (CRC) is the second most prevalent type of cancer in the world. Surgery is the only
curative option. However, postoperative complications occur in up to 50% of patients and are associated with
higher morbidity and mortality rates, lower health related quality of life (HRQoL) and increased expenditure in
health care. The number and severity of complications are closely related to preoperative functional capacity,
nutritional state, psychological state, and smoking behavior. Traditional approaches have targeted the postoperative
period for rehabilitation and lifestyle changes. However, recent evidence shows that the preoperative period might
be the optimal moment for intervention. This study will determine the impact of multimodal prehabilitation on
patients’ functional capacity and postoperative complications.
Methods/design: This international multicenter, prospective, randomized controlled trial will include 714 patients
undergoing colorectal surgery for cancer. Patients will be allocated to the intervention group, which will receive 4
weeks of prehabilitation (group 1, prehab), or the control group, which will receive no prehabilitation (group 2, no
prehab). Both groups will receive perioperative care in accordance with the enhanced recovery after surgery (ERAS)
guidelines. The primary outcomes for measurement will be functional capacity (as assessed using the six-minute
walk test (6MWT)) and postoperative status determined with the Comprehensive Complication Index (CCI).
Secondary outcomes will include HRQoL, length of hospital stay (LOS) and a cost-effectiveness analysis.
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Discussion: Multimodal prehabilitation is expected to enhance patients’ functional capacity and to reduce
postoperative complications. It may therefore result in increased survival and improved HRQoL. This is the first
international multicenter study investigating multimodal prehabilitation for patients undergoing colorectal
surgery for cancer.
Trial registration: Trial Registry: NTR5947 – date of registration: 1 August 2016.
Keywords: Prehabilitation, Colorectal surgery, Functional capacity, Enhanced recovery after surgery,
Comprehensive complication index, Postoperative complications, Colorectal cancer
Background
Colorectal cancer (CRC) is the second most prevalent
type of cancer in the world, with over 1.4 million cases
and 693.900 deaths a year [1]. The only way to cure this
condition is by surgical removal of the tumor. However,
postoperative complications occur in up to 50% of pa-
tients and they are associated with higher morbidity and
mortality rates, increased expenditure on health care
and poorer health related quality of life (HRQoL) [2–4].
Major surgery brings a 20 to 40% reduction in physio-
logical and functional capacity, even in absence of com-
plications [5]. This diminished reserve increases the
level of fatigue up to months after hospital discharge [6].
Only 40% of patients return to their preoperative base-
line functional capacity (as measured by VO2 peak).
Moreover, a proportion of colorectal cancer patients are
eligible for (neo)adjuvant which is known to further
compromise functional recovery and survival [7, 8].
There is emerging evidence suggesting that many of
the negative effects of major surgery can be reduced
through the attenuation of surgical stress [9]. Efforts to
improve the recovery process have primarily focused on
the intraoperative factors (such as minimally invasive
surgery and afferent neural blockade [10]) and postoper-
ative interventions (examples being “fast track” early nu-
trition and mobilization [11]). The latter protocols have
been designed to facilitate the return of functional activ-
ities and accelerate convalescence. However, the postop-
erative period may not be the best time to ask surgical
patients to make significant changes in their nutrition
and exercise since patients are tired and concerned
about perturbing the healing process. As well as anxious
about possible additional treatments for their underlying
condition. The preoperative period may in fact be a bet-
ter time to intervene in the factors that contribute to re-
covery, both physical and mental, and alleviate some of
the emotional distress associated with the anticipation of
surgery and the recovery process [12–14].
The process of improving the functional capacity of
the individual in order to enable them to withstand an in-
coming stressor has been termed prehabilitation [15, 16].
Although some approaches have focused on education to
prepare patients for procedures [17], few steps have been
taken to systematically enhance functional capacity before
surgery. With most studies performing single modal inter-
ventions only. To investigate the impact of preoperative
exercise on the recovery of functional capacity after colo-
rectal surgery, a few pilot studies have been performed
which show promising results [14–16, 18, 19].
Subgroup analysis of the study of Carli et al., showed
that patients whose functional exercise capacity im-
proved preoperatively, recovered relatively well in the
postoperative period - regardless of the exercise tech-
nique [20]. However, one-third of patients deteriorated
preoperatively despite the exercise regimen, and these
patients were also at greater risk of prolonged recovery
after surgery. Poor preoperative physical function (fa-
tigue, malnutrition and physical performance) and the
presence of anxiety and depression were also significant
confounding predictors of prolonged recovery [21–25].
These results suggest that exercise training alone is not
sufficient to attenuate the stress response in all patients
and that it is also important to address factors such as
nutrition and coping behavior that promote beneficial
adaptation to training. Gillis et al. conducted a pilot
study that showed that significant changes in postopera-
tive functional exercise capacity can be achieved with a
prehabilitation program [26]. However, they did not ad-
dress the clinically relevant relationship between pre-
operative functional capacity (an increase of more than
20m on the six-minute walk test (6MWT)), and the
postoperative outcome (comprehensive complication
index (CCI) reduction of 30%). If functional capacity can
be improved preoperatively, we may expect a reduction
in postoperative complications.
Since it has been established that the number and se-
verity of complications are closely related to preopera-
tive functional capacity, nutritional status, smoking
behavior and psychological well-being, there has been
increasing interest in targeting these issues with a multi-
modal intervention program [15]. From a physiological
point of view and based on limited practical experience,
it seems feasible to achieve clinically relevant effects dur-
ing the period of 4–5 weeks between diagnosis and
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operation [14, 15, 27]. However, this can only be achieved
with targeted interventions that include exercise, nutri-
tion, stopping smoking, and psychological support.
Study objectives
The general aim of this study is to investigate whether
multimodal prehabilitation could enhance postoperative
outcome using the CCI and 6MWT. Secondary out-
comes will include patient reported outcome measures
(PROMs) such as HRQoL and depression and anxiety
scores, functional capacity measurements, nutritional and
smoking status, length of hospital stay, study compliance,
patients’ satisfaction and a cost-effectiveness analysis.
Methods
This is an international multicenter, randomized con-
trolled trial with two study groups. Written informed
consent will be obtained from all patients. The trial will
be conducted according to the rules of Good Clinical
Practice and a Data Safety Monitoring Board (DSMB)
has been appointed to monitor (serious) adverse events.
The Netherlands Comprehensive Cancer Organisation
will be responsible for quality control and data man-
agement. Ethical approval for this study was granted
by the Medical Ethics Committee of the Máxima
Medical Center (Veldhoven, the Netherlands) under
reference number W16.100/NL58281.015.16. Import-
ant protocol modifications will be addressed to rele-
vant parties.
Study population
Adult patients (> 18 years) undergoing elective colorectal
resection for cancer are eligible for inclusion. We will in-
clude 714 patients: 357 in each arm. We expect a drop-
out rate of 10% based on previous pilot studies. The
estimated duration of the recruitment period is two
years. Exclusion criteria are metastatic disease known
preoperatively, paralysis or patients with mobility prob-
lems (who are unable to exercise), premorbid conditions
or orthopedic impairments that contraindicated exercise,
cognitive disabilities, chronic renal failure (dialysis or
creatinine > 250 mmol), ASA score 4 or higher, and
illiteracy (inability to read and understand the language
of the country where the study will be performed).
Participating centers
Patients from the Máxima Medical Center (coordinating
hospital, Eindhoven-Veldhoven, the Netherlands), the
Montréal General Hospital (Montréal, McGill, Canada),
Zealand University Hospital (Zealand Region, Denmark),
Foch Hôpital (Paris, France), the Saint Anna University
Hospital of Ferrara (Ferrara, Italy), and Hospital Clinic
de Barcelona (Barcelona, Spain), will be included in
this study.
Randomization
Patients will be block randomized with a 1:1 allocation
by means of randomization software (Research Manager
clinical trial data management system, Deventer, the
Netherlands), stratified by study sites, tumor location
and neoadjuvant treatment. Patients will be allocated ei-
ther to the intervention group, which will receive 4
weeks of prehabilitation, or to the control group, which
will receive no prehabilitation.
In all participating centers, both the investigator and
the surgeon responsible will verify eligibility. If the indica-
tion for surgery is established, patients will be screened by
the medical research team for health conditions that pro-
hibit participation in the program. They will then be called
by the research investigator and an appointment will be
made to provide written and oral information about the
trial during a scheduled outpatient appointment. Patients
will be given enough time to enquire about the details of
the trial and to decide whether or not they wish to partici-
pate. Patients will be required to sign the informed con-
sent form in the presence of the surgeon or investigator.
A participant flow diagram is shown in Fig. 1. After the
study has been explained and consent is obtained, there
will be a multidisciplinary assessment. Based on intake by
the sports physician, the physiotherapist/kinesiologist, the
nutritionist and the case manager/psychologist, an indi-
vidual prehabilitation program will be started during four
weeks in the intervention group.
Study outline
Routine standard preoperative and postoperative clinical
care in the participating institutions do not currently in-
clude special nutrition, exercise and psychological support
to cope with anxiety before surgery. As usual, patients are
evaluated in the preoperative clinic before surgery to deter-
mine whether they are fit for surgery and to adjust their
medication for co-morbid conditions. It is not common
practice after surgery to offer them an in-hospital exercise
program but patients are given generic instructions by the
surgeons about mobilization and returning to normal activ-
ities. Some patients may be referred to a physiotherapist by
their surgeon. Nutrition, exercise and coping strategies will
be introduced solely for research purposes. All patients will
be screened four weeks before surgery to capture insuffi-
cient hemoglobin levels (thresholds in Canada: > 11.2 g/dl,
Europe: > 7mmol/l). Hemoglobin levels in patients with
iron insufficiency will be optimized using iron injections
(ferinject).
Perioperative care will be based on a standardized,
multi-element, evidence-based, comprehensive, ERAS
guideline in line with the consensus review of optimal
care for patients undergoing colorectal surgery [27]. The
guideline will be applied in all participating centers to
improve generalizability.
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The diagnostic work-up for patients with a tumor sus-
pected for malignancy at colonoscopy will be finalized
within one week while awaiting definitive pathology. An
individual treatment strategy will then be proposed by the
multidisciplinary team. Patients that meet the criteria for
the trial will be scheduled approximately five weeks after
the final diagnosis. This schedule allows for the imple-
mentation of a four-week prehabilitation program.
The multidisciplinary multimodal prehabilitation pro-
gram is composed of 4 elements: exercise training, nutri-
tional intervention, smoking cessation and psychological
support. The exact interventions are shown in Table 1
and described in detail below:
Exercise program
An exercise specialist (kinesiologist, sport physician) will
assess the patients’ mobility and his/her capacity to exer-
cise using a cardiopulmonary exercise test (CPET). The
CPET values will be used to establish an individualized
dosing of training embedded in a standardized training
program [28].
– The interval training duration is 28–32min and
performed with 4 min of warm-up at moderate
intensity, 4 intervals of High intensity (2–3 min)
and 4 intervals of Moderate intensity (4 min).
– The workload is dosed at the wattage corresponding
to 90% the peak wattage as attained by the CPET. This
is aimed to result in a metabolic response ranging from
85 to 100% of VO2peak during the high intensity
intervals. This corresponds with a heart-rate of
85–100% of maximal heart rate, and a Borg score of
15–17. Moderate intensity is set at 30% of peak wattage
of the CPET test. This is aimed to have recovery at a
level around or just below Aerobic Threshold.
– If the patient is unable to complete the high-intensity
bout for 4 periods of 2 min (=less than 8min’ exercise
in the high intensity range), the intensity is reduced
by 10 %. The intensity is reduced further – in steps of
10 % – until the patient can complete the 4 bouts of
at least 2 min. If the patient is able to complete all 4
high intensity bouts for 3min (12 min in the high
intensity range) the load is increased with 10%. If
necessary fine-tuning can be done using steps of 5%.
In addition to the preoperative exercise program, pa-
tients will receive information about breathing tech-
niques to prevent pneumonia.
Patients in the intervention group will have three su-
pervised in-hospital training sessions per week during
four weeks. This includes interval training and resistance
training.
Fig. 1 Flow diagram for study participants
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The interval training duration is 28–32min and per-
formed with 4min of warm-up at moderate intensity, 4
intervals of High intensity (2–3min) and 4 intervals of
Moderate intensity (4 min).
The workload is dosed at the wattage corresponding
to 90% the peak wattage as attained by the CPET. This
is aimed to result in a metabolic response ranging from
85 to 100% of VO2peak during the high intensity inter-
vals. This corresponds with a heart-rate of 85–100% of
maximal heart rate, and a Borg score of 15–17 Moderate
intensity is set at 30% of peak wattage of the CPET test.
This is aimed to have recovery at a level around or just
below Aerobic Threshold.
If the patient is unable to complete the high-intensity
bout for 4 periods of 2 min (=less than 8 min’ exercise in
the high intensity range), the intensity is reduced by 10 %.
The intensity is reduced further – in steps of 10 % – until
the patient can complete the 4 bouts of at least 2 min. If
the patient is able to complete all 4 high intensity bouts
for 3min (12min in the high intensity range) the load is
increased with 10%. If necessary fine-tuning can be done
using steps of 5%.
Resistance training is composed as 2 series of 10 repe-
titions of 6 exercises targeting all major muscle groups).
– The strength training consists of two series of 10
repetitions of six exercises: leg press, chest press,
abdominal crunches floor, lat pull down, low row
and step up.
○ In week 1 using 65% of calculated 1RM
(baseline)
○ In week 2 using 70% of calculated 1RM
(baseline)
○ In week 3 using 65% of calculated 1RM
(at 3 weeks).
○ In week 4 using 70% of calculated 1RM
(at 3 weeks)
– The 1RM will be determined at baseline and at 3
weeks using. The strength exercises are performed
according to: 2 s of concentric strength and 2 s of
eccentric strength. The 1RM is calculated by the
Brzycki formula:
○ 1RM = W*36/(37 –r)
W = weight in kilograms
r = repetitions
– The last bout with 10 repetitions needs to be
attainable. If this is not the case in the next session
dosing will be 5–10% lower. If in the last bout it
appears that exercises are to low (≥15 repetitions
will be achieved), in the next sessions dosing will be
5–10% higher.
Patients will also be given instructions about how to
conduct aerobic exercises at home. Patients are instructed
to aim at 60min walking and/or cycling a day, but at least
30 min a day. If possible, patients can do more than
60 min of walking or cycling every day. In case of a
low exercise capacity it is advised to walk/cycle 2–3
times a day for periods of 10–20 min. Also an electric
bicycle, a stationary bicycle and/or a walking aid
(walker) is allowed if necessary.
Patients in both the intervention and control group
will wear an accelerometer for four weeks to count the
number of steps walked in order to record the overall
activity.
The conventional wisdom is that training blocks of
3–5 min are particularly effective in terms of enhan-
cing exercise capacity. Most of the nine studies that
produced the largest increases in VO2max (∼0.85/
min) used blocks of 3–5 min and HIT. Many of these
studies presented either individual data or ranges for
VO2max values pre- and post-training, and an ap-
praisal of these data suggests that a marked training
response was seen in all subjects [29].
In the intervention group we expect to achieve the fol-
lowing improvements after four weeks of prehabilitation
compared to baseline measurements: a 10% increase in
VO2 peak, a 15% increase in VO2 at anaerobic level, a
20–40% increase in 1-RM tests and an increase of > 20
m in the 6MWT [12, 15, 16, 19, 27].
Nutritional assessment and intervention
The nutritionist will complete nutritional assessments at
baseline appointments and during the prehabilitation
program using the patient-generated subjective global
assessment (PG-SGA), body composition (skinfold mea-
surements, mid upper-arm muscle area), hand grip
strength and nutritional intake (caloric and protein in-
take), and a patients’ three-day food diary.
We aim to establish an anabolic condition preopera-
tively. In cachectic and sarcopenic patients we try to in-
crease lean body mass by 1–2 kg or more during four
weeks of prehabilitation. In order to achieve this goal,
the target dietary protein intake will be 1.5–1.8 g/kg
body weight in all patients [16, 30–35].
Participants will receive high-quality protein supple-
ments containing 30 g of whey protein following exercise
and before sleep. Dietary advice will be given in order to
achieve adequate oral protein intake spread properly
across meals. Since vitamin D is associated with muscle
mass and muscle strength [36, 37], vitamin D will be
supplemented daily according to guidelines of the Health
Council of the Netherlands (10 μg for women aged
50-69y, for men <70y and women <50y with colored skin
and/or little sun exposure and 20 μg for women and men
aged 70 y or older) [38]. Besides vitamin D, many elderly
patients may have other micronutrient deficiencies or in-
gest vitamins and minerals below recommended doses
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before and after surgery. Therefore, all other vitamins
and minerals are supplied in a multivitamin/mineral
supplement containing 50% of the recommended daily
allowance.
During the period of hospitalization, the time (in days)
that patients consume nil per mouth is recorded. Also,
on the day of discharge, a trained dietician performs a
24-h recall questionnaire to estimate oral protein- and
energy intake. Nutritional status assessment (PG-SGA)
will be performed at 4 and 8 weeks post-surgery by an
investigator – trained by a registered dietician.
Smoking cessation
A smoking cessation program with intensive counseling
and nicotine replacement therapy (NRT) will be offered
to all patients during the weeks of prehabilitation. Past
and current smoking is measured using questionnaires.
Counselling includes group weekly group sessions and
telephone calls. NRT may consist of any type of replace-
ment therapy. Approximately 15–20% of our patients
are smokers when cancer is diagnosed [13]. The goal
is to achieve a smoking cessation rate of 80% before
surgery.
Psychological coping
It is expected that patients undergoing surgery for can-
cer are anxious with some component of depression.
Since both anxiety and depression can influence the mo-
tivation to carry out social and functional activities, psy-
chological strategies can be put in place to help patients
to cope with the stress of surgery and disease. Therefore,
patients will be screened for anxiety and depression
using the GAD-7 and PHQ-9 questionnaires. If these
questionnaires result in a high score (GAD-7 of 10 or
higher; PHQ-9 score 15 or higher), patients are con-
sidered high-risk and will be offered a referral to a
psychologist. Referred patients will receive a total of
1.5 h of psychological intervention in the first session
and more sessions during the 4 weeks of prehabilita-
tion if necessary.
All patients in the intervention group will be given in-
structions on relaxation and breathing techniques by a
trained investigator. They will be given an instruction
CD, which they can use for relaxation techniques at
home. After the program, patients will be asked if their
perceived usefulness of these techniques. For psycho-
logical support, the intervention group will be contacted
weekly by the investigator by phone. During these 5–15
min phone calls, a researcher will shortly evaluate per-
sonal progression by a standardized set of questions. In
order to enhance adherence to the prehabilitation pro-
gram, all patients in the intervention group will receive
an instructional brochure that includes information
about all elements of the program.
Study outcomes
The initial primary outcome will be postoperative com-
plications, as scored by the Comprehensive Complica-
tion Index [39], with the relevant data being collected as
a continuous variable and calculated using the sum of
morbidity and mortality presented on the Clavien Dindo
classification [40]. The CCI score will be calculated at
the 30 days of follow-up. The second primary outcome
will be the 6MWT measured at 4 weeks after surgery
and compared to baseline. The 6MWT will additionally
be measured directly after prehabilitation and 8 weeks
after surgery.
Secondary outcomes will include patient reported out-
come measurements (PROMs) such as health related
quality of life (HRQoL) (EORTC QLQ-CR29 and
EORTC QLQ-C30 and RAND questionnaires) and de-
pression and anxiety scores (GAD-7, PHQ-9 question-
naires), functional capacity (CPET including VO2max,
VO2peak, AT, the sit to stand test, stair climb test, hand
grip strength and activity questionnaire), nutritional sta-
tus (3-day food diary, PG-SGA, anthropometry), postop-
erative complications, length of hospital stay, study
compliance, patient satisfaction and a cost-effectiveness
analysis. All secondary outcomes are measured at base-
line, the week before surgery, 4 and 8 weeks and 1 year
post-surgery.
Statistical analysis
Baseline characteristics of both groups will be compared
to assess the adequacy of the randomization. Data will
be analyzed on an intention-to-treat basis. In addition, a
per-protocol analysis will be performed. Trial results will
be published in a respective journal. Primary and sec-
ondary outcomes for the intervention and control
groups will be compared.
The primary outcome CCI will be described as the
mean plus the standard deviation (SD). Since we expect
CCI to be right skewed we will also describe CCI as the
median plus interquartile range (IQR) and percentage
above 20. To test the hypothesis (H0) that the study
arms result in similar CCIs (in other words, prehabilita-
tion does not prevent postoperative complications), we
will use the Student’s T-test if data are normally distrib-
uted. Mann-Whitney U if data are not normally distrib-
uted or statistical methods that take into account the
possible zero-inflated nature of the data. The second pri-
mary outcome 6MWT is a continuous variable. This
data will be stated as means, plus SD, at each time point.
To accommodate the repeat measurements for individ-
uals, we will use a generalized linear mixed model to sta-
tistically test the hypothesis of both study arms being
equal in terms of functional capacity over time.
All secondary outcomes will be described as means
plus SD or median plus IQR, with the data being
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continuous, and measures for each time point being
normally and non-normally distributed respectively.
Categorical parameters will be described as number
plus percentage per time point. Statistical methods
will include t-test and the Mann-Whitney U test for
continuous parameters, distributed either normally or
not normally respectively, at a single postoperative
time-point. Categorical outcomes will be analyzed
with Chi-square testing or regression analysis (logistic,
ordinal or nominal, depending on the definition of
the parameter) for single time points. The size of the
sample will be calculated on the basis of the primary
aim: the reduction of postoperative complications as
determined with the CCI score. With our population
variables, the CCI mean is 10.4 (SD 14), and the tar-
get reduction is 30%. We use an alpha of 0.05 and
power of 0.80 (two-sided test). We expect a dropout
rate of 10%. We therefore need 714 patients: 357 in
each arm. This gives us sufficient statistical power to
demonstrate the expected proportion of difference
(55% versus 20%) in the 6MWT between baseline and
surgery based on previous studies [14, 27]. Approxi-
mately 600 eligible CRC patients undergo surgery in
one of the six participating hospitals annually. This
implies that we will complete inclusion within two
years with the inclusion period being followed by a
year of follow-up.
Due to limited clinical data regarding effect size of the
primary endpoint – CCI - an interim analysis will be
performed. The interim analysis is planned if half of the
intended number of subjects have completed the 4 week
assessment (i.e. timing of the primary endpoint assess-
ment). The intention of the interim analysis is to termin-
ate the study if there is a statistical significant difference
between study arms.
Economic evaluation
To analyze cost-effectiveness, we will focus on the re-
sults of the program defined as reduction of complica-
tions, improving survival, less need for postoperative
care and improvements in social productivity. The eco-
nomic evaluation will be performed per participating
center and includes incremental cost-effectiveness and
cost-utility analysis using the RAND and iMTA-PCQ
questionnaires. The cost-effectiveness ratio will be calcu-
lated by dividing the difference between the mean total
costs for the exercise and control groups by the difference
in the mean effect in the groups [41]. The cost-utility ratio
expresses the additional costs of the intervention compared
with the control group per quality-adjusted life years [42].
Discussion
Despite advances in surgical techniques and improve-
ments in postoperative care, morbidity and mortality
remain high in CRC patients undergoing surgery. Post-
operative complications occur in up to 50% of patients
and surgery is associated with a 20 to 40% reduction in
physiological and functional capacity [2–5].
Since we know that the number and severity of com-
plications are, or may be, associated with preoperative
functional capacity, nutritional status, smoking behavior
and psychological well-being, it is incumbent on us to
test a multimodal intervention program that targets
these issues. Traditional approaches have focused on the
postoperative period for rehabilitation and lifestyle
changes. However, recent evidence has shown that the
preoperative period is a better time to intervene [27].
Therefore, we initiated the first international randomized
controlled trial on multimodal prehabilitation for pa-
tients undergoing colorectal surgery for cancer.
Patient lifestyle (stated as inactivity, obesity, dietary
pattern, and smoking behavior) is an important con-
tributor to the development of CRC [43]. Moreover,
CRC patients often develop problems with their nutri-
tional status which may aggravate deconditioning and
muscle wasting (sarcopenia) [31, 32, 44]. This implies
that, particularly in this group of patients, there is con-
siderable potential for improvement in both nutritional
status and functional exercise capacity [45–47]. A recent
review indicated that optimizing functional exercise cap-
acity in the surgical population can, by comparison with
controls, result in fewer postoperative complications,
shorten the length of hospital stay, reduce disability, and
improve quality of life [48]. However, there have been no
previous studies rigorously evaluating the impact of
multimodal prehabilitation prior to digestive surgery.
Interventions that involve physical exercise training
for endurance and strength, nutrition, mental support
and smoking behavior have all found an independent
and clinically relevant effect on the reduction of postoper-
ative complications in small studies. If all these interven-
tions are orchestrated in an innovative prehabilitation
program, it may prove feasible to design a highly effective
and comprehensive intervention. Synergy may result from
these individual interventions if they are applied in a
multimodal program since it is known that protein
supplements one hour after exercise improve uptake and
enhance anabolic effects [30–33, 44, 49]. Nutritional sup-
plementation four weeks before and after surgery has been
shown to enhance preoperative functional walking cap-
acity and recovery in patients undergoing colorectal resec-
tion for cancer [34]. Moreover, the release of dopamine
during exercise improves the psychological mindset
and smoking cessation improves the ability to per-
form exercise.
After the diagnosis of CRC, there is a relatively short
period of 4–5 weeks before the actual surgery. A rigor-
ous intervention program of prehabilitation is therefore
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required that is closely coordinated with the entire med-
ical treatment program. An additional potential benefit
is the empowerment of patients, who may then play an
active role in coping with their disease. From a physio-
logical point of view and based on limited practical ex-
perience, it seems feasible to achieve clinical relevant
effects during the period of four weeks between diagno-
sis and surgery. However, this is possible only with a
combination of robust innovative interventions involving
nutrition, physiological support, smoking cessation and
exercise training. These ideas are supported by Carli et
al., who stated that a multidisciplinary prehabilitation
program needs to be developed, tested, implemented
and delivered to patients [16, 35].
Another reason why optimal recovery after surgery is
important is because it will increase the potential of pa-
tients to withstand additional therapies such as chemo-
therapy, targeted immunotherapy, metastatic disease
resection and/or hyperthermic intraperitoneal chemo-
therapy (HIPEC) [50, 51]. A study by the Dutch cancer
register included 11.000 stage-3 CRC patients (2008–
2013) [7]. 4899 of whom were not treated with chemo-
therapy. The five-year survival rate in this group was
only 39%. If chemotherapy started > 12 weeks postopera-
tively, the five-year survival rate increased to 54%. When
chemotherapy began < 6 weeks after the operation, this
rate increased further to 76%. Improved functional cap-
acity may facilitate an earlier start of adjuvant chemo-
therapy and thereby increasing survival an improving
HRQoL [7, 8, 52, 53].
Despite previous evidence from small-scale trials, there
are currently no standardized prehabilitation programs
and they are therefore not mentioned in current medical
guidelines. This highlights the need to design, test,
optimize, and implement a multimodal program for
maximizing improvements in nutritional status and
functional capacity prior to surgery. We expect to see a
reduction in postoperative complications, Length Of
hospital Stay (LOS), intensive care stay, 30-day mortality
rate, and health expenditure due to the multimodal pre-
habilitation program. The sum of all these separate out-
comes will be measured using the Comprehensive
Complication Index (CCI), which is a relatively new and
interesting outcome measure [40]. As stated in the lit-
erature, patients with postoperative complications report
a lower HRQoL than patients without. We will be the first
to determine whether the HRQoL of patients with postop-
erative complications is inferior both preoperatively and 1
year postoperatively than the HRQoL of patients without
complications. We expect poorer HRQoL in patients with
complications preoperatively and one year postoperatively
than in patients without complications.
Limitations of the study should be noted as well. Due
to its nature this study is performed non-blinded. This
may result in higher dropout rates or an increased activ-
ity level in the control group, due to the growing and in-
tuitive understanding of the benefits of exercise training
and optimal nutrition. To limit this potential bias of in-
creased activity, we will introduce activity trackers to all
patients. We do realize patient characteristics, social cir-
cumstances and healthcare facilities will not be the same
in all countries. Therefore, we will stratify per participat-
ing center. Our international approach of the random-
ized controlled trial will demonstrate that a worldwide
implementation may be possible. In case our multi-
modal program proves to enhance postoperative out-
come, it will be impossible to discover which element
of the program attributed most. A large sample size
and different outcome measurement will facilitate
subgroup analyses, to determine effects of the pro-
gram within different areas, such as functional cap-
acity, body composition, and quality of life. Also, to
allow for comparison of the effects of single modal
interventions in this multimodal program. Our large
sample size will also give us the possibility to analyze
the possible effect differences of an intensive
hospital-based prehabilitation program in different pa-
tient groups. This way, prehabilitation in the current
form can be implemented for patient groups who will
benefit the most from intensive hospital-based train-
ing. For less high-risk patients, future research could
focus on programs in which training is less inten-
sively monitored, such as home-based programs.
Our study investigating prehabilitation is a good
example of research in prevention and it will be the
first to systematically implement existing knowledge
from a variety of different medical specialties and
basic science into a four-element multimodal pre-
operative program for CRC patients with the aim of
improving functional capacity and reducing the post-
operative complication rate.
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